Jack Aiello | CureTalks
Jack Aiello of San Jose, California is a leading patient advocate in multiple myeloma. In January of 1995 Jack had a terrible backache. He was diagnosed with multiple myeloma through a blood test. Since that time Jack has had stem cell transplants and clinical trials that have brought him to remission, even if only for a short time. However, ultimately he had a full allogenic (donor stem cells) transplant, resulting in a long-term remission. While he has long-term side effects, Jack's spirit remains high and is very much involved with cancer advocacy organizations such as the International Myeloma Foundation, Multiple Myeloma Research Foundation, The Leukemia & Lymphoma Society (LLS) and Myeloma Crowd, all of which provide research dollars and education programs for multiple myeloma. He also served on myeloma committees which focus on developing clinical trials, offering his patient perspective to the National Cancer Institute, SWOG Cancer Research Institute, BMT Clinical Trials Network, and Stanford’s Scientific Review Committee.
Related Talks
Myeloma 2015. Year in Review with the MMRF
2015 saw a lot of action in the Myeloma world. Four new drugs were approved by the FDA increasing treatment options and allowing…
Will Modern Therapies Replace Auto and Allo Transplants in Myeloma Treatment?
In just the past 2 months, 3 new drugs for myeloma treatment have been approved by the FDA. In addition to this, there…
A Novel, More Precise, and Effective T-Cell Immunotherapy Approach for Myeloma
A lot of research is being done in immunotherapy for myeloma that is leading to new treatment options for patients. Dr. Ivan Borrello of…
Role of Allogeneic Stem Cell Transplant in Myeloma Treatment with Dr. Krishna Komanduri
The role of allogeneic stem-cell transplantation is evolving in the paradigm of myeloma treatment. Despite its therapeutic potential of a myeloma cure, the…
Understanding Multiple Myeloma: Types of Diagnostic Tests and Frequency
Myeloma presents itself differently in each patient. In order to understand your Myeloma and monitor it, you need to know which are the…